GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B2, HSD17B3, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, TRPV1 |
14.4192 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APP, AR, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTGS1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
12.3964 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
12.3834 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
12.3834 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
12.1736 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
11.6876 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
11.6777 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FUT7, HSD17B3, HSPA1A, PIK3CA, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR, XDH |
11.2512 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TRPV1, TYR |
10.9105 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
10.8704 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
10.8592 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
10.6668 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TEK, TRPV1, TYR |
10.6668 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
10.4512 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
10.3498 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
10.3498 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
9.91651 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
9.65541 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
9.60922 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, HSD11B1, HSD17B2, HSD17B3 |
9.56061 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.50515 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
9.50515 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
9.39328 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
9.38927 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.38927 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, NR3C1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TEK, TRPV1, TYR |
9.27983 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TRPV1 |
9.27983 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
9.27662 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PIK3CA, PPARA, RELA, SMAD3, SRC, TEK, TYR |
9.19973 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, NR3C1, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK, TRPV1 |
9.19945 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
9.18906 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 |
9.09352 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA6, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
9.07884 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.73413 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, NQO2, PTGS1, RORC |
8.73413 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
8.67845 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
8.61538 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, NR3C1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
8.5441 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.06709 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD17B2, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TRPV1, TYR |
8.06709 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, NR3C1, PIM1, PPARA, RELA, RORC, SRC |
8.04758 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
8.04051 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
8.04051 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
7.98635 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.97073 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
7.85746 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HSD11B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
7.7383 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TRPV1 |
7.53068 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, ALOX12, APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.37054 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, ALOX12, APP, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.35078 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.29782 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.23424 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
7.19894 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
7.19894 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, ALOX12, APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.19894 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.15057 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, ALOX12, AR, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TEK, TERT |
7.07724 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, ALOX12, APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.04632 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, ALOX12, APP, CACNA1C, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.01561 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
7.01052 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B2, HSD17B3, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2 |
6.99454 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.95198 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.95198 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ALOX12, APP, AR, AXL, CA2, CACNA1C, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HCAR2, HSPA1A, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
6.94426 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, ALOX12, APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.87386 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.8582 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
6.81572 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.76456 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SRC, TRPV1 |
6.69242 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT, TRPV1 |
6.69242 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
6.69242 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.67704 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC, TEK, XDH |
6.63534 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
6.6071 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.60647 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.5743 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.5049 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
6.44646 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
6.40119 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ALOX12, APP, AR, AXL, CA2, CYP1B1, EGFR, ESRRB, F3, HCAR2, HSPA1A, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, TERT, TRPV1 |
6.38144 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
6.36813 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.36813 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
6.29017 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC, TEK, XDH |
6.27371 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
6.2588 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.24106 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
6.17616 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
6.11387 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, KCNH2, MAP2K1, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
6.02127 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, ALOX12, APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, TRPV1 |
5.99248 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.98474 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
5.98474 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
5.98474 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
5.97649 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.94695 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
5.90687 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HCAR2, HSD11B1, HSD17B2, HSD17B3 |
5.87613 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TRPV1 |
5.82853 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B2, HSD17B3 |
5.74675 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, RORC, SMAD3, SRC, TEK, TYR |
5.73883 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.73173 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.66851 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
5.62902 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.52425 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX12, ALOX15, AR, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
5.41138 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
5.36469 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR |
5.36309 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
5.3564 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.35295 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B2, HSD17B3 |
5.34052 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.30193 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
5.25558 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
5.24499 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
5.23145 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
5.22692 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B3, MAOA, TYR |
5.2267 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.20671 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.16864 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
5.15857 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KCNH2, KDR, NR3C1, PTGS2, RELA, SRC, TRPV1 |
5.10873 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
5.05849 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 |
5.05379 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
5.01675 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
4.99212 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.97413 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
4.94976 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR |
4.90607 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, PIK3CA, RELA, SMAD3, TYR |
4.75628 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.71659 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KCNH2, KDR, NR3C1, PTGS2, RELA, SLC6A2, SLC6A4, SRC, TRPV1 |
4.68535 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CSNK2A1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
4.65389 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, PTGES, PTGS1, PTGS2 |
4.6473 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
4.6473 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGES, PTGS2, TERT |
4.62085 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, EGFR, HCAR2, KDR, PIK3CB, PTGS2, SRC, TRPV1 |
4.60792 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.59674 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SLC6A4, SRC |
4.58754 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, INSR, MAOA, PTGS2, SLC6A2, SLC6A4, SMAD3, TRPV1 |
4.57277 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, EGFR, HCAR2, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
4.54125 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
4.53714 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK, TRPV1, TYR |
4.52219 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.52219 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TRPV1 |
4.45027 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
4.45027 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B2, HSD17B3 |
4.43286 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.43286 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.41201 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, EGFR, ESR1, F3, FABP4, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, SMAD3, TEK |
4.36478 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, RELA, SRC |
4.34715 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK |
4.33984 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
4.32965 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, PTGS2, RELA, SRC, TEK, TRPV1 |
4.28152 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.24414 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
4.20442 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MAP3K7, MET, PIK3CA, PIK3CB, PPARA, PTPN1, RELA, SMAD3 |
4.19262 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, HSD17B3, PTGES, PTGS1, PTGS2 |
4.17186 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
4.17186 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, HSPA1A, MAOA |
4.1486 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1, TERT |
4.14748 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5, PTGS2 |
4.14748 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, HSD17B3, TYR |
4.13976 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, RORC, SRC, TEK |
4.13678 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK, TRPV1, TYR |
4.12905 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.11142 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.05232 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, NR3C1, PPARA, PTGS2, RELA, RORC, SMAD3, SRC, TERT, TRPV1 |
4.01944 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
4.00342 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.00107 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
3.99913 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.99469 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.97256 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.96571 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.96571 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.92872 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
3.91374 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MAP2K1, MET, PIK3CB, PIM1, SRC, TEK, TYR |
3.90373 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TYR, XDH |
3.88464 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, RELA, SRC |
3.87111 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, EGFR, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.84834 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, RELA, SLC6A4, SRC, TRPV1 |
3.82032 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, RELA, SMAD3, SRC, TRPV1 |
3.82005 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, CYP3A4, HSD11B1, HSD17B2, HSD17B3 |
3.81799 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
3.81799 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, MAP2K1, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.80132 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.78687 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTGS2, RELA, SLC6A4, TEK, TRPV1, TYR |
3.73499 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.69912 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.69859 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.69859 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.63896 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
3.63409 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, PTGS2, RELA, RORC, SMAD3, SRC, TERT, TRPV1 |
3.62425 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.62308 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
3.61569 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, PTGS2, SRC |
3.61569 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, HCAR2, MET, PIK3CA, PPARA, RELA, SMAD3 |
3.59986 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, HSPA1A, MAP2K1, PTGES, PTGS2, SLC6A4, SMAD3, TERT, XDH |
3.5857 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.5741 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.55339 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
3.55328 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, RELA, SLC6A4, SRC, TRPV1 |
3.52794 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
3.51713 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.5069 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, KDR, MAP2K1, PTPN1, SRC, TEK |
3.47083 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
3.47083 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
3.47083 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA, TRPV1 |
3.47083 |
[BP] GO:0014074 |
response to purine-containing compound
|
APP, PTGS2, RELA, SLC6A4, TEK, TRPV1, TYR |
3.4416 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, NR3C1, RELA, RORC, SLC6A4, SRC |
3.42115 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, RELA, SMAD3, SRC, TRPV1 |
3.41484 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TERT, XDH |
3.41235 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.40918 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
3.39058 |
[BP] GO:0006693 |
None
|
CES2, PTGES, PTGS1, PTGS2 |
3.36423 |
[BP] GO:0006692 |
None
|
CES2, PTGES, PTGS1, PTGS2 |
3.36423 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT |
3.34605 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.33868 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.3356 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.32707 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.3255 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, F3, KDR, PTGS2, TEK, TERT |
3.31313 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, RELA, SMAD3, SRC, TEK, TRPV1 |
3.30042 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
3.29936 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.29684 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, EGFR, FLT3, NR3C1, PTGS2, RELA, SRC |
3.29587 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
3.29587 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
3.29587 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.2584 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.2584 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, MMP2, MMP9, PTGS2, SLC6A4, SRC |
3.22941 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
3.1684 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, CYP1B1, DUSP3, KDR, MAP3K7, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.1684 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.16296 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, MAP3K7, PIM1, RELA |
3.1483 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, RELA, SMAD3, TEK |
3.1483 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, CYP2D6, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
3.09398 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, ESRRB, F3, INSR, KDR, MAP2K1, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, TERT |
3.08651 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
3.08523 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.08064 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CACNA1C, CYP1B1, EGFR, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, RELA, SRC, TEK |
3.0745 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, MAP3K7, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, RELA, SMAD3, SRC |
3.07176 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.04129 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2C19, CYP2D6, CYP3A4, MAOA |
3.04069 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
3.01438 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
ALOX12, CYP1B1, F3, KDR, PTGS2, TEK, TERT |
3.002 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.002 |
[BP] GO:0019371 |
None
|
PTGES, PTGS1, PTGS2 |
3.002 |
[BP] GO:1902893 |
None
|
PPARA, RELA, SMAD3, TERT |
3.002 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.002 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
2.99605 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, MET, PIK3CA, TRPV1 |
2.96916 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
2.9679 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
2.94788 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, ESR1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.94788 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
2.91252 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.90412 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
2.89448 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.89448 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.88015 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87835 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.87835 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.87835 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.87835 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.87505 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 |
2.87211 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, NR3C1, SRC |
2.866 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, CACNA1C, EGFR, GPR35, HCAR2, KCNH2, PTGS2, SMAD3, TRPV1 |
2.86481 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.8575 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC, TRPV1 |
2.81931 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.81197 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AR, EGFR, ESR1, FLT3, INSR, NR3C1, RELA, SRC |
2.81197 |
[BP] GO:0001516 |
None
|
PTGES, PTGS1, PTGS2 |
2.80686 |
[BP] GO:0046457 |
None
|
PTGES, PTGS1, PTGS2 |
2.80686 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
2.80681 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.79704 |
[BP] GO:0007584 |
response to nutrient
|
CYP1A1, EGFR, PTGS2, RELA, SLC6A4, TRPV1, TYR |
2.77602 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, F3, INSR, KDR, MAP2K1, PIM1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.77502 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
2.77502 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, SRC |
2.77382 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.77086 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.73518 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, MAP2K1, SRC, TEK |
2.72759 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
2.72759 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
2.72418 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.72223 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, MAP3K7, PIK3CB, PPARA, PTPN1 |
2.7197 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.70663 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
2.70032 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MAP2K1, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
2.69437 |
[BP] GO:0033273 |
response to vitamin
|
CYP1A1, EGFR, PTGS2, RELA, TYR |
2.68566 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
2.68566 |
[BP] GO:0040008 |
regulation of growth
|
ALOX12, APP, AR, CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIK3CA, PIM1, SLC6A4, SMAD3 |
2.6704 |
[BP] GO:0043434 |
None
|
FABP3, INSR, PPARA, PTGS2, RELA, SRC, TEK, TRPV1 |
2.66328 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK |
2.66317 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
2.65973 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.65188 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.64349 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
2.64251 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
2.64251 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TERT |
2.64251 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.63223 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.63223 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.62107 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, GPR35, KCNH2, MMP9, PTGS2 |
2.61398 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC |
2.61398 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC, TRPV1 |
2.61054 |
[BP] GO:0006633 |
None
|
ALOX12, ALOX15, PTGES, PTGS1, PTGS2 |
2.60917 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.60917 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57086 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR, TERT |
2.57043 |
[BP] GO:0000122 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, TRPV1 |
2.56657 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, NR3C1, PIK3CB, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
2.559 |
[BP] GO:0045893 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.559 |
[BP] GO:1903508 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.559 |
[BP] GO:1902680 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.55611 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, HSPA1A, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TERT |
2.52109 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX12, ALOX15, CYP1A1, PTGES, PTGS1, PTGS2 |
2.51453 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MMP12, SLC6A4, SRC, TRPV1 |
2.51453 |
[BP] GO:0008217 |
None
|
ADORA1, AR, PPARA, PTGS1, PTGS2, SMAD3 |
2.50104 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT |
2.49889 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.49889 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.49889 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.49889 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49889 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.49889 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.49889 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2, SLC6A4 |
2.47476 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2, SLC6A4 |
2.47476 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, CACNA1C, EGFR, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.44315 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.43891 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, HSPA1A, MAP3K7, MMP12, PTGS2, RELA, SMAD3, SRC |
2.42858 |
[BP] GO:0031331 |
positive regulation of cellular catabolic process
|
ADRA2A, ESRRB, HSPA1A, INSR, KDR, MAP3K7, PIK3CB, PPARA, PTPN1 |
2.42858 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, HCAR2, PIK3CB, PTGS2 |
2.42642 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.4224 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, CA2, CA9, CACNA1C, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, RELA, SLC6A4, SMAD3, SRC, TEK |
2.41835 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
2.37546 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, PTPN1, SRC |
2.372 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.36388 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.3621 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.34941 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.34941 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.34719 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, CACNA1C, GPR35, KCNH2, MMP9, PTGS2, SLC6A4 |
2.3461 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.3364 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.33269 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.33269 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.33269 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.33269 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.32599 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.31636 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, KDR, MAP2K1, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
2.30176 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
KDR, PIK3CB, SMAD3, SRC, TEK |
2.30176 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, HSPA1A, RELA, SRC, TERT |
2.30176 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.30176 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.30176 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PTGS2, RELA, SRC |
2.2697 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.26922 |
[BP] GO:0001889 |
liver development
|
CSNK2A1, EGFR, PIK3CA, RELA, SMAD3 |
2.26748 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, MAP3K7, RELA |
2.26261 |
[BP] GO:0030258 |
lipid modification
|
ALOX12, CYP1A1, CYP3A4, EGFR, MET, PIK3CA, PIK3CB |
2.26261 |
[BP] GO:0046328 |
regulation of JNK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP3K7, PTPN1 |
2.25693 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.25448 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.25448 |
[BP] GO:0055080 |
cation homeostasis
|
APP, CA2, CA7, CACNA1C, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
2.25448 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.25448 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25448 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25448 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25448 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.25157 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.24437 |
[BP] GO:1901342 |
regulation of vasculature development
|
ALOX12, CYP1B1, F3, KDR, PTGS2, TEK, TERT, XDH |
2.24437 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.23426 |
[BP] GO:1902895 |
None
|
RELA, SMAD3, TERT |
2.23405 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.23405 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.23405 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.23405 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.23405 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, ALOX12, APP, AXL, CYP1B1, EGFR, FUT7, KDR, MAP2K1, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK |
2.22563 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
2.22508 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, AXL, CA2, CA9, CYP1B1, EGFR, HSPA1A, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, RELA, SRC, TERT, TRPV1 |
2.21472 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, SRC |
2.20014 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, KDR, MMP12, TEK |
2.19999 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AXL, CYP1A1, EGFR, PTGS2, RELA, SLC6A4, SRC, TRPV1, TYR |
2.19553 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.18661 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, HSPA1A, MAOA, PIK3CB, SRC, XDH |
2.18359 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18304 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.15408 |
[BP] GO:0051253 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT, TRPV1 |
2.14789 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.13798 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.13798 |
[BP] GO:0045892 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TRPV1 |
2.13705 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.13705 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.13705 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.13705 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.13705 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.12546 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.11682 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, EGFR, ESR1, PTGS2, SLC6A4, SRC |
2.1058 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, KDR, MAP2K1, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.08901 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.08901 |
[BP] GO:0045934 |
None
|
ADRA2A, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RELA, RORC, SMAD3, SRC, TERT, TRPV1 |
2.07871 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, CACNA1C, CSNK2A1, EGFR, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.07871 |
[BP] GO:0046394 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, PTGES, PTGS1, PTGS2 |
2.07871 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, PTGS2, SLC6A4 |
2.07871 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.07871 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07871 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.07871 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.07871 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.07871 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.07871 |
[BP] GO:0016053 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, PTGES, PTGS1, PTGS2 |
2.07127 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, PIK3CB, PTPN1, SMAD3, SRC, TEK |
2.06816 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, KDR, PIK3CB, SMAD3, SRC, TEK |
2.06714 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.06113 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.05919 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.05734 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.05734 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.05734 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.04844 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
2.03065 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, EGFR, FUT7, KDR, MAP2K1, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.0236 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.01483 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.00465 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.00465 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ESR1, F10, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 |
4.58585 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
4.5368 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, F10, FLT3, HSD11B1, HSD17B2, HSD17B3, PTGES, PTGS1, PTGS2, PTPN1 |
4.03173 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, NQO2, NR3C1, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, TRPV1, TYR, XDH |
3.88693 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.3968 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.27653 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.2584 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KCNH2, KDR, MAOA, MET, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TEK, TRPV1, TYR |
3.03677 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HSD17B3, HSPA1A, KDR, MAP2K1, PTGS2, PTPN1, XDH |
2.89448 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.86507 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.72418 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PTGS2, SLC6A2, SLC6A4, SRC, TEK, TRPV1 |
2.72418 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, AOX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TYR, XDH |
2.49889 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, HSD11B1, HSD17B2, HSD17B3, PTGES, PTGS1, PTGS2 |
2.49889 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK, TRPV1 |
2.37717 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.32594 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, KCNH2, MET, SLC6A2, TEK |
2.14588 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, AOX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CA9, CACNA1C, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TYR, XDH |
2.07871 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
18.8599 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
15.047 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH |
12.7596 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
11.7333 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH |
9.38927 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HSD11B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
9.27533 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH |
9.19945 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PPARA, PTPN1, RORC, SMAD3 |
8.48362 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, XDH |
8.48032 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A4, SRC, TEK, TRPV1 |
7.85746 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.35078 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, NR3C1, RORC, SHBG |
7.23009 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
7.15026 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
7.04623 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.00802 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
6.78547 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.76456 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 |
6.57009 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.46799 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
6.44646 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, TYR |
6.37682 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.34732 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.34732 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.29777 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, RORC, SMAD3, TEK, TRPV1 |
6.11387 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, IGF1R, INSR, NQO2, NR3C1, SHBG |
6.07298 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
6.07298 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
6.00744 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, NR3C1, PPARA, RORC, SHBG, TRPV1 |
5.886 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.82853 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.74796 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, TYR |
5.74675 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, NQO2, PTGES, PTGS1, PTGS2, SRC, XDH |
5.31802 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.22287 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
5.10873 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.0455 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
4.97714 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT |
4.90122 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
4.88189 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
4.79253 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, NQO2, PTGS2, RELA, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH |
4.76144 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP2D6, CYP3A4 |
4.33258 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, KCNH2, MET, NR3C1, PPARA, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK |
4.17186 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGES, RELA, SRC, TEK, TRPV1, XDH |
3.87213 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
3.77824 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.65708 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B2, HSD17B3, XDH |
3.62039 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5, PTGS2 |
3.36423 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5, PTGS2 |
3.30728 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.2584 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.2584 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PTPN1, SRC, TEK |
3.16093 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.16093 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
3.03878 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
2.8949 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.87835 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87835 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.87835 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.79989 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.68405 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.65188 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AR, AXL, EGFR, FLT3, KCNH2, NQO2, PTGS2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
2.63421 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.58803 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
2.52436 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, FLT3, KCNH2, NQO2, PTGS2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
2.52271 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1, XDH |
2.51172 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.49889 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.49889 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.49889 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.49889 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.49889 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.49889 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PPARA, RELA, RORC, SMAD3 |
2.43492 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.32594 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PPARA, RELA, RORC, SMAD3 |
2.31139 |
[MF] GO:0001047 |
None
|
ESR1, ESR2, ESRRB, MMP12, NR3C1, RELA |
2.26748 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.26748 |
[MF] GO:0047485 |
None
|
CSNK2A1, HSPA1A, MAP2K1, RELA, TERT |
2.25448 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25448 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.25448 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.25448 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25448 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.25448 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.25448 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1, XDH |
2.14428 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1, XDH |
2.14353 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, RELA, SMAD3, SRC |
2.1058 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.09241 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.07871 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07871 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.07871 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B2, HSD17B3 |
2.07392 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH |
2.06873 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.03763 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B2, HSD17B3 |
2.0125 |